Asia Pacific Medical Technology Association (APACMed)

APACMed is thrilled to announce that Nobel Laureate and global icon Malala Yousafzai will take centre stage at this year’s MedTech Forum, taking place on September 5th and 6th at the Suntec Convention Centre. This highly anticipated event focuses squarely on Artificial Intelligence (AI) and how it’s revolutionising the entire healthcare landscape. https://medtechforum.asia/ We are also excited to have Guest-of-Honour, Senior Minister of State for Ministry of Trade and Industry (Singapore) and Ministry of Culture, Community and Youth (MCCY), Ms. Low Yen Ling, join us this year. Malala Yousafzai will explore the transformative potential of education in enhancing healthcare access for millions in Asia and how technology can accelerate this progress. She will join an impressive lineup of game changers, including Tom Lawry (unconventional thought leader), Matthew Luhn (master storyteller) Dr. Brent James (healthcare systems innovator) and Associate Professor Tam C. Nguyen (AI research specialist). This global lineup of speakers will address how AI is future-proofing healthcare, transitioning from digital to intelligent systems that promise more personalised and effective patient care.   Register now for the MedTech Forum 2024, happening on 5-6 September 2024 at the Suntec Convention Centre: https://lnkd.in/dx5P-9_n #GameChangersMTF #APACMTF Malala Fund | Wedu | John Collings | Stryker | Vy Tran | Siemens Healthineers | John Eng | Singapore Economic Development Board (EDB) | Vikram Kapur | Bain & Company | Harjit Gill | Probir Das | Chee Hong L. | Farhana Nakhooda | Dong Feng | Lance Little | Stephen Morse | Marc Radatt | Paul Tan | Pavan Kumar Mocherla | Vishnu Kalra | Punit Kohli

APACMed 2024 Regulatory Affairs Forum On the 4th September, APACMed’s members gathered for a one-day forum dedicated to our valuable RA community. The event featured regulators from Australia, Indonesia, Japan, Korea, Malaysia, Singapore, and Vietnam, who kicked off the day by sharing exciting updates and plans for 2025. This provided members with firsthand insights into what to anticipate in the coming year. In the afternoon, Mahesh Datar (Medtronic) presented on Real-World Evidence (RWE), followed by a panel discussion with regulators moderated by Miang (Chadaporn) T. (Johnson & Johnson). The forum concluded with presentations by Johan Ordish (Roche) and Cassie Scherer (Medtronic) on the Predetermined Change Control Plan (PCCP), followed by a panel moderated by RAMA Sethuraman (Roche) with the regulators We extend our gratitude to our RA members for their participation and to the distinguished regulators for their continued support and collaboration with APACMed. See you next year! Aidahwaty Ariffin, Muralitharan Paramasua, Tracey Duffy, Nazmi, Madoka Murakami, Mi-Jung Son, Le Van Dung, Doan Quang Minh, Cindy Pelou, Devya Bharati

A warm welcome to our latest cooperate member, CooperVision a unit of The CooperCompanies Inc. CooperVision is a global leader in contact lenses, dedicated to helping improve the way people see each day. The company offers innovative solutions for myopia, astigmatism, and presbyopia. They are crossing new frontiers in research and development. This is demonstrated through their groundbreaking products, such as MiSight® 1 day, the first FDA-approved soft contact lens proven to slow the progression of short-sightedness in children. Kathy Park (박유경)

We thank the Asia Pacific MedTech Forum 2024 sponsors for their generous support. Thank you for believing in our vision! #APACMTF 

Did you know that there is a more efficient way to search for resources on our website? With advanced search functionality such as filters, you can find what you need quickly with the launch of the new APACMed Resource Hub. All Your Resources, One Platform – Quick and Easy Search. Explore it now: https://lnkd.in/gZ6J2wZr

What Does It Take to Realize the Value of AI in Asia Pacific MedTech? The Asia Pacific region holds immense potential for AI-driven healthcare transformation, with the Asia-Pacific AI MedTech market expected to grow at a substantial 28% between 2024 and 2028 (compared to the global average of 44.4%). However, numerous challenges stand in the way of fully realising this potential. Our new whitepaper developed in partnership with KPMG, “Realizing the Value of AI in MedTech in Asia Pacific”, explores the factors hindering the full realization of AI’s value in Asia Pacific MedTech. We discuss key enablers, opportunities, and recommendations for stakeholders to overcome these hurdles. Read the paper: https://lnkd.in/gzXeFpTP

Learn how to leverage regulatory intelligence to anticipate changes, mitigate risks, and seize opportunities with the APACMed eLearning Hub. The APACMed eLearning Hub features: - High quality content created by APACMed’s Regulatory Affairs experts - Real-world insights on the latest regulations, technologies, and best practices - Virtual modules available on-demand - Certification to showcase your expertise Stay on top of your game by visiting the APACMed eLearning Hub now: https://apacmed.academy

Please join us in welcoming Solventum, our latest corporate member. Solventum, formerly 3M Health Care, is now an independent healthcare company with over 22,000 employees worldwide and sales in more than 90 countries. Rooted in over 70 years of history, Solventum is a proven global leader in large, diverse and growing markets, creating breakthrough solutions to solve big healthcare challenges that change patient lives for the better while enabling healthcare professionals to perform at their best. See more at Solventum.com. Marina Fernhout-Mollemans

Shanghai Yangtze River Delta Medical Device Industry Development Promotion Association (SD-MDA), our latest industry association member, is a key platform in China for advancing the medical device industry. It engages in various activities, such as seminars, policy interpretation, and technical exchanges to foster technological innovation and regulatory development within the region. The association acts as a crucial link within China's medical device sector, supporting the establishment and revision of regulations, enhancing industry competitiveness and development levels, and promoting high-quality and sustainable growth of the medical device industry in the Yangtze River Delta and beyond.

Cancer continues to burden APAC's healthcare systems and patients. We need innovation. Next-Generation Sequencing (NGS) is here. This powerful technology unlocks a tumour's unique genetic makeup, enabling personalised treatment plans. Imagine faster diagnoses, targeted therapies, and improved outcomes. NGS is the future of cancer care. Studies show it can streamline diagnostics, identify ideal therapies, and even reduce costs. But uneven access and a narrow focus on just clinical benefits limit its potential. Let's change that. Join us as we embrace what's next in cancer care. By working together, we can unlock the power of NGS and usher in a new era of personalised medicine for all patients in APAC. Read our whitepaper: https://lnkd.in/dbq-RMxj Join the NGS Working Group: Contact Binderiya M. and Anirudh Sen #EmbracingWhatsNext #ValueofDiagnostics #NextGenSequencing